CS logo
small CS logo
Republican Siauliai Hospital

Siauliai, Lithuania
Hospital in Šiauliai
V. Kudirkos g. 99, Šiauliai 76231

About Republican Siauliai Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Amgen
2
Bayer
2
Eli Lilly and Company
2
Impax Laboratories, LLC
2
ALK-Abelló A/S
1
Bausch Health Americas, Inc.
1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
1
Hoffmann-La Roche
1
Idorsia Pharmaceuticals Ltd.
1
Lipid Therapeutics GmbH
1
Pfizer
1
Total Rows: 13

Clinical Trials at Republican Siauliai Hospital


During the past decade, Republican Siauliai Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11111100221111110022110000330011Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
2008-06-01
2010-04-01
Completed
514
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
2009-04-01
2010-11-01
Completed
381
A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
2009-12-01
2012-02-01
Unknown status
156
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
2010-03-01
2011-10-01
Completed
617
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
2010-09-30
2017-02-09
Completed
505
Diltiazem Hydrochloride Cream for Anal Fissure
2010-10-01
2012-05-01
Completed
465
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
2010-12-09
2017-08-16
Completed
529

Rows per page:

1–17 of 17

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Republican Siauliai Hospital" #1 sponsor was "Amgen" with 2 trials, followed by "Bayer" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Impax Laboratories, LLC" with 2 trials sponsored and "ALK-Abelló A/S" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Republican Siauliai Hospital" #1 collaborator was "Cosmo Technologies Ltd" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAmgen: 2Amgen: 2Bayer: 2Bayer: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Impax Laboratories, LLC: 2Impax Laboratories, LLC: 2ALK-Abelló A/S: 1ALK-Abelló A/S: 1Bausch Health Americas, Inc.: 1Bausch Health Americas, Inc.: 1Daiichi Sankyo Europe,GmbH, a Daiichi SankyoCompany: 1Daiichi Sankyo Europe,GmbH, a Daiichi SankyoCompany: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1Idorsia Pharmaceuticals Ltd.: 1Idorsia Pharmaceuticals Ltd.: 1Lipid Therapeutics GmbH: 1Lipid Therapeutics GmbH: 1

Created with Highcharts 11.1.0Top CollaboratorsCosmo Technologies Ltd: 1Cosmo Technologies Ltd: 1Incyte Corporation: 1Incyte Corporation: 1

Clinical Trials Conditions at Republican Siauliai Hospital


According to Clinical.Site data, the most researched conditions in "Republican Siauliai Hospital" are "Atrial Fibrillation" (2 trials), "Parkinson's Disease" (2 trials), "Psoriatic Arthritis" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Republican Siauliai Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Republican Siauliai Hospital


Most popular intervention types in "Republican Siauliai Hospital" are "Drug" (14 trials), "Other" (4 trials), "Biological" (3 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Baricitinib" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Republican Siauliai Hospital


The vast majority of trials in "Republican Siauliai Hospital" are 17 trials for "All" genders.

Clinical Trials Status at Republican Siauliai Hospital


Currently, there are NaN active trials in "Republican Siauliai Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Republican Siauliai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Republican Siauliai Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 15Phase 3: 15Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 11Completed: 11Active, not recruiting: 3Active, not recruiting: 3Enrolling by invitation: 1Enrolling by invitation: 1Recruiting: 1Recruiting: 1Unknown status: 1Unknown status: 1